Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 6/20 | 0.52 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | NOS3 | P29474 | 1/20 | 0.36 |
| ▸ | NOS1 | P29475 | 1/20 | 0.36 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.35 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3257515 | 1.00 | SLC6A4 (0.52) | SLC6A4MAOASLC6A2SLC6A3KDM4E | |
| SCHEMBL28529746 | 1.00 | SLC6A4 (0.52) | SLC6A4MAOASLC6A2SLC6A3KDM4E | |
| SCHEMBL8370128 | 1.00 | SLC6A4 (0.52) | SLC6A4MAOASLC6A2SLC6A3KDM4E | |
| SCHEMBL8694485 | 1.00 | SLC6A4 (0.52) | SLC6A4MAOASLC6A2SLC6A3KDM4E | |
| SCHEMBL3252828 | 1.00 | SLC6A4 (0.52) | SLC6A4MAOASLC6A2SLC6A3KDM4E | |
| Hydrochloric Acid SCHEMBL8531133 | 0.98 | SLC6A4 (0.50) | SLC6A4MAOASLC6A2SLC6A3KDM4E | |
| SCHEMBL8954525 | 0.85 | SLC6A4 (0.61) | SLC6A4MAOASLC6A2SLC6A3KDM4E | |
| SCHEMBL9039099 | 0.84 | SLC6A4 (0.50) | SLC6A4MAOASLC6A2SLC6A3KDM4E | |
| SCHEMBL9658639 | 0.84 | SLC6A4 (0.50) | SLC6A4MAOASLC6A2SLC6A3KDM4E | |
| SCHEMBL8367079 | 0.84 | SLC6A4 (0.50) | SLC6A4MAOASLC6A2SLC6A3KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106365351-B | A kind of sewage purifier and its purification method based on chemical neutralisation and nanofiltration technique | 徐州筱翔知识产权服务有限公司 | 2019-06-21 | — | — | CN | claimed |
| CN-106365351-A | Sewage purification device and purification method based on chemical neutralization method and nanofiltration technology | 徐州工程学院 | 2017-02-01 | — | — | CN | claimed |
| CN-106362505-A | Automatic silencing dedusting facility in straw flocculant production and operating principle thereof | 徐州工程学院 | 2017-02-01 | — | — | CN | claimed |
| EP-3095486-A2 | FIRE EXTINGUISHING COMPOSITION COMPRISING ALCOHOL PHENOL COMPOUND AND DERIVATIVE THEREOF | Xi'an J&R Fire Fighting Equipment Co., Ltd. (CN) | 2016-11-23 | — | — | EP | claimed |
| EP-3095487-A1 | FIRE EXTINGUISHING COMPOSITION COMPRISING ALDOKETONES COMPOUND | Xi'an J&R Fire Fighting Equipment Co., Ltd. (CN) | 2016-11-23 | — | — | EP | claimed |
| US-20160332014-A1 | Fire Extinguishing Composition Comprising Alcohol Phenol Compound and Derivative Thereof | NANO FIRE, LLC | 2016-11-17 | — | — | US | claimed |
| US-20120041225-A1 | KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF | VAIDYA NITEEN A (US) | 2012-02-16 | — | — | US | claimed |
| EP-1981831-A2 | KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF | Vaidya, Niteen A. (US) | 2008-10-22 | — | — | EP | claimed |
| WO-2007092264-A2 | KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF | VAIDYA NITEEN A (US) | 2007-08-16 | — | — | WO | claimed |
| US-20070185346-A1 | Kit for automated resolving agent selection and method thereof | VAIDYA NITEEN A | 2007-08-09 | — | — | US | claimed |
| EP-0719755-B1 | Process for the preparation of the enantiomers of 2-(2-fluoro-4-biphenyl)-propionic acid | ZAMBON SPA (IT) | 1999-02-10 | — | — | EP | claimed |
| US-5840964-A | Process for the preparation of the enantiomers of 2-(2-fluoro-4-biphenyl)propionic acid | ZAMBON GROUP S.P.A. (IT) | 1998-11-24 | — | — | US | claimed |
| EP-0719755-A1 | Process for the preparation of the enantiomers of 2-(2-fluoro-4-biphenyl)-propionic acid | ZAMBON GROUP S.p.A. (IT) | 1996-07-03 | — | — | EP | claimed |
| EP-0272684-B1 | DERIVATIVES OF N-(METHYLSULPHONYLPHENYLETHYL)-2-PROPENAMIDES AND THEIR USE AS ANTIBIOTICS | ZAMBON S.p.A. (IT) | 1991-06-12 | — | — | EP | claimed |
| EP-0272684-A2 | Derivatives of N-(methylsulphonylphenylethyl)-2-propenamides and their use as antibiotics | ZAMBON S.p.A. (IT) | 1988-06-29 | — | — | EP | claimed |
| JP-8253440-A | — | — | None | — | — | JP | disclosed |
| CN-112694608-B | Six-arm polyethylene glycol derivative, preparation method and modified biological related substance | 厦门赛诺邦格生物科技股份有限公司 | 2024-07-02 | — | — | CN | disclosed |
| EP-0272684-A2 | Derivatives of N-(methylsulphonylphenylethyl)-2-propenamides and their use as antibiotics | ZAMBON S.p.A. (IT) | 1988-06-29 | — | — | EP | disclosed |
| US-4743700-A | Process for fluorinating 1-phenyl-2-amino-1,3-propanediol compounds | ZAMBON S.P.A. (IT) | 1988-05-10 | — | — | US | disclosed |
| EP-0130633-A2 | Process for the preparation of 1-(phenyl)-1-hydroxy-2-amino-3-fluoro propane derivatives | ZAMBON GROUP S.p.A. (IT) | 1985-01-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120041225-A1 | KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF | ACKR3, KIT, C3AR1 | SLC6A4 2681/4885MAOA 2076/4885SLC6A2 4293/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.